 CARLSBAD, Calif., Dec. 07, 2022 GLOBE NEWSWIRE Qualigen Therapeutics, Inc. Qualigen or the Company, Nasdaq: QLGN, a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that it has received feedback from the FDA following a pre-Investigational New ... The post Qualigen Therapeutics Announces Pre-IND Feedback from U.S. Food and Drug Administra... 